2.0
3 Jul 2020
Current employee, more than 3 years
Reading, England
Recommend
CEO approval
Business outlook
Pros
The company is highly respected and a world leader in R&D and Health Data
Cons
People are overworked and the leadership (within EMEA TA) are very junior The majority of the team are very disappointed with the leadership. It’s very junior in EMEA and I can’t think of one good thing to say unfortunately. It’s a culture of self promotion which is really unhealthy